Pyridam Farma Tbk PT
IDX:PYFA
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Goldman Sachs Group Inc
NYSE:GS
|
Financial Services
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Albemarle Corp
NYSE:ALB
|
Chemicals
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
| US |
|
Netflix Inc
NASDAQ:NFLX
|
Media
|
| US |
|
Apple Inc
NASDAQ:AAPL
|
Technology
|
| US |
|
NVIDIA Corp
NASDAQ:NVDA
|
Semiconductors
|
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
Retail
|
| US |
|
Alphabet Inc
NASDAQ:GOOGL
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
89
1 400
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Goldman Sachs Group Inc
NYSE:GS
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Albemarle Corp
NYSE:ALB
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
|
|
Netflix Inc
NASDAQ:NFLX
|
US |
|
|
Apple Inc
NASDAQ:AAPL
|
US |
|
|
NVIDIA Corp
NASDAQ:NVDA
|
US |
|
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
US |
|
|
Alphabet Inc
NASDAQ:GOOGL
|
US |
This alert will be permanently deleted.
Pyridam Farma Tbk PT
Pyridam Farma Tbk PT
Accrued Liabilities
Pyridam Farma Tbk PT
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Accrued Liabilities
Rp98.5B
|
CAGR 3-Years
101%
|
CAGR 5-Years
89%
|
CAGR 10-Years
48%
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Accrued Liabilities
Rp146B
|
CAGR 3-Years
19%
|
CAGR 5-Years
8%
|
CAGR 10-Years
4%
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Accrued Liabilities
Rp630.5B
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Accrued Liabilities
Rp372.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
17%
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Accrued Liabilities
Rp174.4B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Accrued Liabilities
Rp513.5B
|
CAGR 3-Years
59%
|
CAGR 5-Years
28%
|
CAGR 10-Years
24%
|
|
Pyridam Farma Tbk PT
Glance View
PT Pyridam Farma Tbk engages in the production and development of pharmaceutical medicines, and trading of medical supplies. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,539 full-time employees. The company went IPO on 2001-10-16. The firm operates through two segments: Pharmaceutical Products and Toll Manufacturing Services, and Medical Device Products. Its business consists of production and/or distribution of modern and traditional medicines and distribution of medical devices, such as laboratory equipment and PCR test kits. The company offers products across consumer health, prescription, pyfaesthetic and biomedilab categories. The company produces various kinds of pharmaceuticals products ranging from antibiotics, vitamins and health supplements. The firm offers its products in the form of effervescent tablets, capsules, caplets, syrups and creams. Its prescription production has several properties, such as anti-infection, anti-inflammatory, anti-parkinsonian, anti-epileptic, and other indications. The company provides toll manufacturing services to produce products owned by the Company’s partner companies in accordance with predetermined specifications.
See Also
What is Pyridam Farma Tbk PT's Accrued Liabilities?
Accrued Liabilities
98.5B
IDR
Based on the financial report for Sep 30, 2024, Pyridam Farma Tbk PT's Accrued Liabilities amounts to 98.5B IDR.
What is Pyridam Farma Tbk PT's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
48%
Over the last year, the Accrued Liabilities growth was 131%. The average annual Accrued Liabilities growth rates for Pyridam Farma Tbk PT have been 101% over the past three years , 89% over the past five years , and 48% over the past ten years .
You don't have any saved screeners yet
